← Scroll for more →
Valneva SE (VALN)
Biological Products, (No Diagnostic Substances)
Latest Price
$5.71
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
2.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2.29M | $11.0M | 1.32% | -- | 2026-06-30 |
| Vivo Capital, LLC | 763.2K | $3.0M | 0.44% | -- | 2026-06-30 |
| General American Investors Co Inc | 354.4K | $1.0M | 0.20% | -- | 2026-06-30 |
| Millennium Management LLC | 135.2K | -- | 0.08% | -- | 2026-06-30 |
| Wells Fargo & Company | 77.2K | -- | 0.04% | -815 | 2026-06-30 |
| Morgan Stanley | 56.2K | -- | 0.03% | +9.3K | 2026-06-30 |
| Ironwood Investment Management LLC | 45.1K | -- | 0.03% | +19.9K | 2026-06-30 |
| Citadel Advisors LLC | 20.3K | -- | 0.01% | -3.2K | 2026-06-30 |
| XTX Topco Ltd | 15.2K | -- | 0.01% | +4.5K | 2026-06-30 |
| VSM Wealth Advisory, LLC | 10.0K | -- | 0.01% | -- | 2026-06-30 |